28.02.2013 Views

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Cytogenetics</strong> <strong>of</strong> Solid Tumors 429<br />

domyosarcomas are characterized by reciprocal chromosome translocations involving the FKHR<br />

(Forkhead transcription factor) gene on chromosome 13, whereas embryonal rhabdomyosarcomas<br />

lack such translocations. Most alveolar rhabdomyosarcomas have fusion <strong>of</strong> the FKHR gene with the<br />

PAX3 gene on chromosome 2 (40–42), but a smaller number contain fusions <strong>of</strong> FKHR with the PAX7<br />

gene on chromosome 1 (43). Notably, the PAX7-FKHR fusion is <strong>of</strong>ten highly amplified—in the form<br />

<strong>of</strong> double minute chromosomes—whereas the more common PAX3-FKHR fusions are not. This difference<br />

appears to reflect the lower intrinsic expression <strong>of</strong> PAX7-FKHR, relative to that <strong>of</strong> PAX3-<br />

FKHR, with genomic amplification therefore required to provide a comparable level <strong>of</strong> oncogene<br />

transcript (44). <strong>The</strong> normal FKHR, PAX3, and PAX7 genes encode transcription factors, and the<br />

PAX3-FKHR and PAX7-FKHR fusion oncogenes encode activated forms <strong>of</strong> those transcription factors<br />

(45,46). Embryonal rhabdomyosarcomas typically lack FKHR translocations and have a distinctive<br />

cytogenetic pr<strong>of</strong>ile including extra copies <strong>of</strong> chromosomes 2, 8, and 20. Deletions <strong>of</strong> chromosome<br />

11p have been studied extensively in embryonal rhabdomyosarcoma, and for some time, they were<br />

viewed as the cardinal cytogenetic aberrations in these tumors. However, the 11p deletions are infrequent<br />

compared to the chromosomal polysomies.<br />

Synovial Sarcoma<br />

Synovial sarcomas can be either biphasic (in which the tumor contains both spindle cell and epithelioid<br />

elements) or monophasic (in which the tumor is predominantly spindle cell), and both <strong>of</strong> these<br />

subtypes feature a reciprocal translocation involving the X chromosome and chromosome 18,<br />

t(X;18)(p11.2;q11.2) (47,48). <strong>The</strong> (X;18) translocation is found in more than 90% <strong>of</strong> synovial sarcomas,<br />

but not in histologic mimics such as hemangiopericytoma, mesothelioma, leiomyosarcoma, or<br />

malignant peripheral nerve sheath tumor. <strong>The</strong> molecular underpinnings <strong>of</strong> the (X;18) translocation are<br />

complex in that the oncogene on chromosome 18 (SYT or SS18) can be fused with either <strong>of</strong> two nearly<br />

identical genes (SSX1 or SSX2) on the X chromosome (49). SSX1 and SSX2 are neighboring genes, and<br />

given their close proximity, it is impossible to distinguish SYT-SSX1 and SYT-SSX2 translocations using<br />

conventional chromosomal banding methods. However, the alternate SSX fusions can be demonstrated<br />

by FISH (see Chapter 17, Fig. 13) or RT-PCR (50,51). Notably, synovial sarcomas with the SYT-SSX1<br />

fusion are invariably biphasic, whereas those with SYT-SSX2 can be either biphasic or monophasic and<br />

have better metastasis-free survival compared to those with SYT-SSX1 fusions (52).<br />

Adipose Tumors<br />

Adipose tumors present a paradigm in solid-tumor cytogenetics, in that virtually all histological<br />

subtypes, whether benign or malignant, contain distinctive chromosomal aberrations (see Table 1).<br />

Useful diagnostic markers include 12q rearrangement in lipoma, ring chromosomes in well-differentiated<br />

and dedifferentiated liposarcoma, t(12;16) translocations in mxyoid/round cell liposarcoma,<br />

and cytogenetic complexity in pleomorphic liposarcomas.<br />

Benign lipomas can be grouped into three general cytogenetic categories: (1) those with rearrangements<br />

<strong>of</strong> the mid-portion <strong>of</strong> the long arm <strong>of</strong> chromosome 12 (band 12q15); (2) those with clonal aberrations<br />

not involving 12q15; and (3) those with normal karyotypes (53–55). <strong>The</strong> chromosome 12q15<br />

rearrangements target the HMGIC (high-mobility group IC) transcriptional regulatory gene (56), with<br />

formation <strong>of</strong> an HMGIC fusion oncogene, usually resulting from an inversion or translocation with various<br />

partner chromosomes. Other nonrandom aberrations include rearrangement <strong>of</strong> the short arm <strong>of</strong> chromosome<br />

6 and deletion <strong>of</strong> the long arm <strong>of</strong> chromosome 13, which are each seen in fewer than 10% <strong>of</strong><br />

lipomas (54). Lipomas with deletions <strong>of</strong> the long arm <strong>of</strong> chromosome 16, <strong>of</strong>ten accompanied by deletions<br />

<strong>of</strong> the long arm <strong>of</strong> chromosome 13, generally have spindle cell or pleomorphic histology (55,57).<br />

Characteristic cytogenetic aberrations are found in several other benign adipose tumors. Lipoblastomas<br />

are pediatric adipose tumors containing variable numbers <strong>of</strong> primitive cells (lipoblasts), and these tumors<br />

generally contain translocations involving the long arm <strong>of</strong> chromosome 8 at bands 8q11-q12, which result

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!